Fig. 3

Molecular signatures of plasma-derived EVs from LUSC and BLD patients. (A) Volcano plot of identified proteins in LUSC vs. BLD. Proteins with significantly increased abundance are colored in red, and proteins with lower abundance are colored in blue. (B) Principal component analysis for BLD and LUSC samples. (C) GO pathway enrichment results for LUSC. (D) GO pathway enrichment results for BLD. (E) KEGG pathway analysis for LUSC. (F) KEGG pathway analysis for BLD